SCHEMBL3981600

SCHEMBL3981600

NNC(=O)c1occ(-c2ccc(Cl)cc2)c1-c1ccc(Cl)cc1

nearest known ligand 0.48

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
GAA P10253 4/20 0.47
ALDH1A1 P00352 4/20 0.46
KDM4E B2RXH2 3/20 0.46
MAPT P10636 3/20 0.46
LMNA P02545 2/20 0.46
L3MBTL1 Q9Y468 1/20 0.46
MEN1 O00255 2/20 0.44
KMT2A Q03164 2/20 0.44
TLR9 Q9NR96 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.43
RAB9A P51151 1/20 0.40
GFER P55789 1/20 0.40
HDAC1 Q13547 1/20 0.38
HDAC8 Q9BY41 1/20 0.38
HDAC6 Q9UBN7 1/20 0.38
ALOX15 P16050 1/20 0.37
ALOX12 P18054 1/20 0.37
PIK3CA P42336 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3978704 0.85 OGG1 (0.46) GAAALDH1A1KDM4EMAPTL3MBTL1
SCHEMBL3982631 0.85 ALDH1A1 (0.41) GAAALDH1A1KDM4EMAPTLMNA
SCHEMBL3977739 0.84 GAA (0.43) GAAALDH1A1KDM4EMAPTL3MBTL1
SCHEMBL3975726 0.81 AURKA (0.40) ALDH1A1KDM4EMAPTSMN1; SMN2RAB9A
SCHEMBL3975197 0.79 SLC6A3 (0.51) ALDH1A1KDM4EMAPTLMNAL3MBTL1
SCHEMBL4282784 0.77 CDC7 (0.45) GAAALDH1A1KDM4EMEN1KMT2A
SCHEMBL3982902 0.77 CA1 (0.46) GAAALDH1A1KDM4EMAPTLMNA
SCHEMBL3976993 0.73 ALDH1A1 (0.35) GAAALDH1A1KDM4EMAPTLMNA
SCHEMBL3976989 0.71 S1PR3 (0.40) KDM4ELMNA
SCHEMBL3976458 0.68 GAA (0.36) GAAALDH1A1KDM4EMAPTL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7514452-B2 2-furancarboxylic acid hydrazides and pharmaceutical compositions containing the same DAINIPPON PHARMACEUTICAL CO., LTD (JP) 2009-04-07 US disclosed
US-20050171196-A1 2-Furancarboxylic acid hydrazides and pharmaceutical compositions containing the same DAINIPPON SUMITOMO PHARMA CO., LTD. (JP) 2005-08-04 US disclosed
EP-1489077-A1 2-FURANCARBOXYLIC ACID HYDRAZIDES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME DAINIPPON PHARMACEUTICAL CO., LTD. (JP) 2004-12-22 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050171196-A1 2-Furancarboxylic acid hydrazides and pharmaceutical compositions containing the same GLP1R, GCGR, GPR119 GAA 1023/4885ALDH1A1 1389/4885KDM4E 2769/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.